No Prescription |
 |
 | ||
|
PLENDIL Generic Felodipine |
|
| ||
No Prescription » Prescription Drugs 13 » PLENDIL Generic Felodipine Plendil is indicated in the treatment of hypertension. PLENDIL may be used alone or concomitantly with other antihypertensive agents. Plendil is prescribed for the treatment of high blood pressure. It is effective alone or in combination with other high blood pressure medications. A type of medication called a calcium channel blocker Plendil eases the workload of the heart by slowing down its muscle contractions and the passage of nerve impulses through it. This improves blood flow through the heart and throughout the body reduces blood pressure and helps prevent angina pain (chest pain often accompanied by a feeling of choking usually caused by lack of oxygen in the heart due to clogged arteries).Felodipine is in a class of drugs called calcium channel blockers. Felodipine relaxes (widens) your blood vessels (veins and arteries) which makes it easier for the heart to pump and reduces its workload.Felodipine is used to treat hypertension (high blood pressure). Buy PLENDIL Generic Felodipine and other Prescription Drugs 13 products online at Medstore. Buy Online at Medstore - Click Here!
About PLENDIL Generic Felodipine: Product Type: Prescription Drugs 13 PLENDIL ( Generic Felodipine ) PLENDIL (Generic Felodipine) Generic Felodipine 10mg Generic Felodipine PLENDIL
View more Prescription Drugs 13 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
